lung cancer
Conditions
Interventions
of 
peripheral 
blood 
APO10 
and 
by 
EDIM
Sponsors
Beijing Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. CT found pulmonary nodules, diameter <= 3cm; 2. Surgical removal of pulmonary nodules, including wedge resection, segmentectomy or lobectomy; 3. Voluntarily join the research project and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. A history of oncology or a combination of other malignancies; 2. suffering from any infectious disease in the past month; 3. merge any autoimmune disease; 4. EDIM testing is not possible within 8 weeks prior to blood draw: Medication: anti-rheumatic drugs (including but not limited to the following drugs): methotrexate, sulfasalazine, hydroxychloroquine and leflunomide; celecoxib; Corticosteroids (including but not limited to the following): Cortef and cortisone, Celestone, Prednisone Intensol, Preparon ; Radiation Therapy; Chemotherapy; Immunomodulatory therapy; Vaccine; surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity;Specificity; | — |
Secondary
| Measure | Time frame |
|---|---|
| positive predictive value;negative predictive value;ACC;AUC of ROC; | — |
Countries
China
Contacts
Public ContactTong Hongfeng
Beijing Hospital
Outcome results
None listed